This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Myriad Genetics' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Myriad Genetics, Inc. (MYGN)

Q1 2012 Earnings Call

May 1, 2012 4:30 pm ET

Executives

Rebecca Chambers – Director of Investor Relations

Peter D. Meldrum – President and Chief Executive Officer

Mark C. Capone – President, Myriad Genetic Laboratories

James S. Evans – Chief Financial Officer and Treasurer

Analysts

Scott Gleason – Stephens Inc.

John Wood – Jefferies & Company, Inc

Amanda Murphy – William Blair & Company, L.L.C.

Michael Yee – RBC Capital Markets

William T. Cook – Piper Jaffray, Inc.

Doug Schenkel – Cowen and Co.

Tycho W. Peterson – JPMorgan Securities LLC

David Ferreiro – Oppenheimer Securities

Isaac Ro – Goldman Sachs

Kevin DeGeeter – Ladenburg Thalmann Securities

Presentation

Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Myriad Genetics 2012 Third Quarter Earnings Call. During the presentation, all participants will be in a listen-only mode. Afterwards we’ll conduct a question-and-answer session. (Operator Instructions) As a reminder, this conference is being recorded Tuesday, May 1, 2012.

I would now like to turn the conference over to Ms. Rebecca Chambers, Director of Investor Relations. Please go ahead.

Rebecca Chambers

Good afternoon everyone, and welcome to the Myriad Genetics’ Third Fiscal Quarter Earnings Call. During the call, we will review the financial results we released today and the progress made this quarter on our strategic directives, after which we will host a question-and-answer session. If you have not had a chance to review the earnings release it can be found in the Investor Relations section of our website at myriad.com.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,528.03 -114.98 -0.69%
S&P 500 1,972.18 -16.69 -0.84%
NASDAQ 4,776.5080 -51.8170 -1.07%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs